NCT03628326 (SEGPUL) is a clinical trial of Pulmonary arterial tree in Pulmonary Artery Stenosis, sponsored by Centre Hospitalier Universitaire, Amiens.

Who is sponsoring NCT03628326?

NCT03628326 is sponsored by Centre Hospitalier Universitaire, Amiens.

What drugs are being tested in NCT03628326?

Interventions in NCT03628326: Pulmonary arterial tree.

What condition does NCT03628326 study?

NCT03628326 studies Pulmonary Artery Stenosis.

Is NCT03628326 still recruiting?

NCT03628326 is currently completed. Last updated 14 August 2018.

Last reviewed 2018-08-14 · How we verify

NCT03628326: SEGPUL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Visceral Pleural Lumbar Lymphatic Drainage

Completed Last updated 14 August 2018

What this trial tests

trial testing Pulmonary arterial tree in Pulmonary Artery Stenosis in 44 participants. Completed in 1 August 2017.

Timeline

1 April 2016

Primary endpoint
1 August 2017

1 August 2017

Quick facts

Lead sponsor	Centre Hospitalier Universitaire, Amiens
Status	Completed
Study type	OBSERVATIONAL
Enrollment	44
Start date	1 April 2016
Primary completion	1 August 2017
Estimated completion	1 August 2017

Drugs / interventions tested

Pulmonary arterial tree

Conditions studied

Pulmonary Artery Stenosis — all drugs for Pulmonary Artery Stenosis →

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

Adults 50 to 75, any sex, with Pulmonary Artery Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anatomic variations of the pulmonary arterial tree can cause technical difficulties during pulmonary lobectomy in general and video-assisted thoracic surgery (VATS). Using CT angiography and 3D reconstruction, the investigators sought to identify anatomic variations of the pulmonary arterial tree and assess their respective frequencies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pulmonary Artery Stenosis

Currently open trials in the same condition.

NCT05086016 — Growth Trial: Study of the Renata Minima Stent · NA · active not recruiting
NCT03287024 — BeGrow Study to Treat Pulmonary Artery (PA) Stenosis in Newborns and Infants · NA · active not recruiting

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
NCT07071662 — Induction of Labor in Breech Presentation · completed
NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03628326 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
Last refreshed: 14 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03628326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing